A new fructose-free, resistant-starch type IV-enriched enteral formula improves glycaemic control and cardiovascular risk biomarkers when administered for six weeks to elderly diabetic patients.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Concepción M Aguilera Angel Gil Cruz Erika García-Rodríguez |
| Publication date | February 1, 2017 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |